Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference53 articles.
1. US renal data system 2015 annual data report: Epidemiology of kidney disease in the United States;Saran;Am J Kidney Dis,2016
2. Fracture risk in kidney transplant recipients: A systematic review;Naylor;Transplantation,2013
3. Low-dose pamidronate for treatment of early bone loss following kidney transplantation: A randomized controlled trial;Shahidi;Iran J Kidney Dis,2015
4. Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation;Haas;Kidney Int,2003
5. CKD-mineral and bone disorder management in kidney transplant recipients;Alshayeb;Am J Kidney Dis,2013
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-06-22
2. Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society;Bone;2019-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3